These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. S3-guideline "helicobacter pylori and gastroduodenal ulcer disease" of the German society for digestive and metabolic diseases (DGVS) in cooperation with the German society for hygiene and microbiology, society for pediatric gastroenterology and nutrition e. V., German society for rheumatology, AWMF-registration-no. 021 / 001. Fischbach W; Malfertheiner P; Hoffmann JC; Bolten W; Bornschein J; Götze O; Höhne W; Kist M; Koletzko S; Labenz J; Layer P; Miehlke S; Morgner A; Peitz U; Preiss J; Prinz C; Rosien U; Schmidt W; Schwarzer A; Suerbaum S; Timmer A; Treiber G; Vieth M; ; ; Z Gastroenterol; 2009 Dec; 47(12):1230-63. PubMed ID: 19960402 [TBL] [Abstract][Full Text] [Related]
3. Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report. Malfertheiner P; Mégraud F; O'Morain C; Hungin AP; Jones R; Axon A; Graham DY; Tytgat G; Aliment Pharmacol Ther; 2002 Feb; 16(2):167-80. PubMed ID: 11860399 [TBL] [Abstract][Full Text] [Related]
4. [Short version of the S3 (level 3) guideline "Helicobacter pylori and gastroduodenal ulcer disease" from the German Society for Digestive and Metabolic Diseases]. Fischbach W; ; ; ; Dtsch Med Wochenschr; 2009 Sep; 134(37):1830-4. PubMed ID: 19728254 [TBL] [Abstract][Full Text] [Related]
5. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Malfertheiner P; Megraud F; O'Morain C; Bazzoli F; El-Omar E; Graham D; Hunt R; Rokkas T; Vakil N; Kuipers EJ Gut; 2007 Jun; 56(6):772-81. PubMed ID: 17170018 [TBL] [Abstract][Full Text] [Related]
7. Are twelve days of omeprazole, amoxicillin and clarithromycin better than six days for treating H. pylori infection in peptic ulcer and in non-ulcer dyspepsia? Gisbert JP; Hermida C; Pajares JM Hepatogastroenterology; 2001; 48(41):1383-8. PubMed ID: 11677970 [TBL] [Abstract][Full Text] [Related]
8. Current consensus on the diagnosis and treatment of H. pylori-associated gastroduodenal disease. Suzuki H; Masaoka T; Nomura S; Hoshino Y; Kurabayashi K; Minegishi Y; Suzuki M; Ishii H Keio J Med; 2003 Sep; 52(3):163-73. PubMed ID: 14529149 [TBL] [Abstract][Full Text] [Related]
9. [Helicobacter pylori eradication. Therapeutic evolution, value of complementary studies]. Bigard MA Presse Med; 2001 Sep; 30(26):1305-12. PubMed ID: 11603094 [TBL] [Abstract][Full Text] [Related]
11. [The attitude of primary health care physicians in the metropolitan area of Barcelona about the diagnosis and treatment of Helicobacter pylori infection in gastroduodenal diseases]. Martínez-Sánchez G; Saperas E; Benavent J; Mearin F; Piñol JL; Barenys M; Mascort JJ; Forné M; Bordas JM; Azagra R; Piqué JM Gastroenterol Hepatol; 1998 Dec; 21(10):473-8. PubMed ID: 9927791 [TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori and peptic ulcer disease. Current evidence for management strategies. Chiba N; Lahaie R; Fedorak RN; Bailey R; Veldhuyzen van Zanten SJ; Bernucci B Can Fam Physician; 1998 Jul; 44():1481-8. PubMed ID: 9678277 [TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of eight Helicobacter pylori antigens among 182 patients with peptic ulcer, MALT gastric lymphoma or non-ulcer dyspepsia. Higher rate of seroreactivity against CagA and 35-kDa antigens in patients with peptic ulcer originating from Europe and Africa. Lamarque D; Gilbert T; Roudot-Thoraval F; Deforges L; Chaumette MT; Delchier JC Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):721-6. PubMed ID: 10445790 [TBL] [Abstract][Full Text] [Related]
14. Update S2k-Guideline Helicobacter pylori and gastroduodenal ulcer disease of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS). Fischbach W; Bornschein J; Hoffmann JC; Koletzko S; Link A; Macke L; Malfertheiner P; Schütte K; Selgrad DM; Suerbaum S; Schulz C; Z Gastroenterol; 2024 Feb; 62(2):261-321. PubMed ID: 38364851 [No Abstract] [Full Text] [Related]
15. Efficacy and cost-effectiveness of the 13C-urea breath test as the primary diagnostic investigation for the detection of Helicobacter pylori infection compared to invasive and non-invasive diagnostic tests. Nocon M; Kuhlmann A; Leodolter A; Roll S; Vauth C; Willich SN; Greiner W GMS Health Technol Assess; 2009 Oct; 5():Doc14. PubMed ID: 21289901 [TBL] [Abstract][Full Text] [Related]